Table 1 Baseline characteristics of the study cohort
Variables | Observation (N = 70) |
|---|---|
Age (mean ± SD, years) | 55.91 ± 14.08 |
Gender | |
Male (%) | 45 (64.3%) |
APACHE-II score (mean ± SD) | 17.17 ± 4.42 |
SOFA score (mean ± SD, day 1) | 5.71 ± 2.05 |
Height (mean ± SD, cm) | 158.45 ± 5.89 |
Haemoglobin (mean ± SD, gm/dl) | 12.29 ± 2.07 |
Haematocrit (mean ± SD, gm/dl) | 39.55 ± 7.32 |
Leukocyte counts (mean ± SD, per dl) | 13,799 ± 4998 |
Blood Urea [median (interquartile range), mg/dl] | 54 (13–191) |
Serum creatinine [median (interquartile range), mg/dl] | 0.9 (0.3–4.7) |
Serum bilirubin [median (interquartile range), mg/dl] | 0.6 (0.2–3.7) |
Serum albumin (mean ± SD, gm/dl) | 3.17 ± 0.49 |
Serum calcium (mean ± SD, gm/dl) | 8.02 ± 0.76 |
Serum phosphate (mean ± SD, gm/dl) | 3.27 ± 1.12 |
Anterior arm muscle thickness (mean ± SD, mm) | 23.13 ± 4.83 |
Quadriceps muscle thickness (mean ± SD, mm) | 31.21 ± 8.56 |
Source of infection | |
Lower respiratory tract | 67(95.7%) |
Urinary tract | 3(4.3%) |
Co-morbidities | |
COPD | 40(57%) |
Asthma | 7(10%) |
Bronchiectasis | 7(10%) |
Interstitial lung diseases | 2(3%) |